These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Merck opts for shake-up to clear drug pipeline. Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975 [No Abstract] [Full Text] [Related]
9. Drug research--a change of paradigms. Müllner S Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454 [No Abstract] [Full Text] [Related]
10. What drives operational performance in clinical R&D? Ringel M; Martin L; Hawkins C; Panier V; Denslow M; Buck L; Schulze U Nat Rev Drug Discov; 2016 Mar; 15(3):155-6. PubMed ID: 26846158 [No Abstract] [Full Text] [Related]
11. Aligning pharmaceutical innovation with medical need. Nathan C Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145 [No Abstract] [Full Text] [Related]
12. A changing drug supply. Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432 [No Abstract] [Full Text] [Related]
13. Drug life-cycle technologies. Fleming E; Ma P Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253 [No Abstract] [Full Text] [Related]
14. Strategic trends in the vaccine market. Kresse H; Shah M Nat Rev Drug Discov; 2010 Dec; 9(12):913-4. PubMed ID: 21119727 [No Abstract] [Full Text] [Related]
15. Brand-name drug companies fail to meet R&D commitments. Kondro W CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891 [No Abstract] [Full Text] [Related]
16. Mixed scores for European research. Chipman A Nature; 2007 Nov; 450(7166):16-7. PubMed ID: 17972849 [No Abstract] [Full Text] [Related]
17. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
18. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008. Glah D; Tear S IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888 [No Abstract] [Full Text] [Related]
19. A place in the sun. Abbott A Nature; 2007 Mar; 446(7132):124-5. PubMed ID: 17344823 [No Abstract] [Full Text] [Related]
20. The future of best investing in vaccines: the Health Technology Assessment approach. La Torre G; de Waure C; Chiaradia G; Mannocci A; Specchia ML; Nicolotti N; Ricciardi W Vaccine; 2008 Mar; 26(13):1609-10. PubMed ID: 18289744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]